RenovoRx Inc

NASDAQ:RNXT   1:00:00 PM EDT
1.36
+0.06 (+4.62%)
4:15:45 PM EDT: $1.37 +0.01 (+0.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)49.74M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.33 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$1.33
50-Day MA$1.22
200-Day MA$1.14
See more pivots

RenovoRx Inc Stock, NASDAQ:RNXT

2570 West El Camino Real, Suite 320, Mountain View, California 94040
United States of America
Phone: +1.650.284.4433
Number of Employees: 8

Description

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.